Skip to main content
Caplight Logo









5Metis, Inc.

5Metis, Inc.

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://www.5metis.com/

Last Round

VC Round

May 21, 2025

Total Funding Raised

$21M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

5Metis, Inc. is a biotechnology company that specializes in the discovery and early development of novel agrichemical products for crop protection.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

agrichemicalfungicide discoverycrop protectionagtechsmall molecule discoverysynthetic biologyboron-based chemistrydrug discoverybiotechlicensing platformagricultural innovationR&D platformcrop resistance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

5Metis, Inc. Comparables

Compare 5Metis, Inc. with similar companies based on industry and business-model similarity.

5Metis, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Enko
80%
Moa Technology
75%
Bindwell
74%

5Metis, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 21, 2025
GrantAug 1, 2024
Series A ExtensionApr 30, 2024
GrantApr 26, 2022
Series AOct 4, 2021

Key People

Founding team and executive leadership

Brian Green

Chief Executive Officer and Chief Scientific Officer

Executive Team

Rich Gianni

Chief Financial Officer

Executive Team

Steven Tuttle

COO at 5Metis Inc.

Executive Team

5Metis, Inc. Investors

Notable investors and investment history

5Metis, Inc. investors
InvestorRounds
Gates FoundationGrant
1855 CapitalSeries A, Series A Extension
Ospraie Ag ScienceSeries A Extension, Series A
Mountain Group PartnersSeries A, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors grew 154% MoM.

  • Nov 13, 2024

    Monthly visitors increased 97% MoM.

5Metis, Inc. Filings

Explore SEC and related filing metadata, where available.

5Metis, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about 5Metis, Inc.'s valuation, stock price, and market status.

Is 5Metis, Inc. a public or private company?

5Metis, Inc. is a private company.

What is the current stock price of 5Metis, Inc.?

5Metis, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is 5Metis, Inc. worth (valuation)?

Valuation information for 5Metis, Inc. is not publicly available.

Can I buy 5Metis, Inc. stock?

5Metis, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was 5Metis, Inc.'s last funding round?

5Metis, Inc.'s most recent funding round was VC Round on May 21, 2025.

Who are the main investors in 5Metis, Inc.?

Key investors in 5Metis, Inc. include Ospraie Ag Science.

Will 5Metis, Inc. IPO soon?

No public IPO plans have been announced for 5Metis, Inc..

How can I track 5Metis, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 5Metis, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range14
Year Founded2021
Last FundingMay 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?